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Abstract 
Background: Renovascular hypertension accounts for 51–52 % of all cases of hypertension in the general popula-
tion, but plays a major role in treatable causes for hypertension in the young. This entity consists of renal vascular ath-
erosclerosis (90 %), commonly seen among the elderly population, and renal fibro muscular dysplasia (FMD) (10 %), 
predominantly seen in the young. The prevalence of clinically significant renal artery fibromuscular dysplasia is 0.4 %.
Case presentation: We present a case of treatable young hypertension in a 29 year old female, who was diagnosed 
with renovascular hypertension due to fibromuscular dysplasia of the left renal artery.  Computed tomographic 
angiogram revealed significant stenosis of the left main renal artery. Diethylene triamine penta acetic acid reno-
gram showed a small left kidney due to renal artery stenosis. She underwent left sided nephrectomy, and histology 
revealed features of FMD, after which she achieved full recovery with normalization of blood pressure, and did not 
require antihypertensive drug treatment.
Conclusions: Fibromuscular dysplasia causing renal artery stenosis, though a rare cause of renovascular hyperten-
sion, is essential to be considered in young hypertensives, even in the absence of family history of hypertension. A 
high index of suspicion is necessary in early diagnosis and prompt treatment, which can result in rapid and complete 
recovery.
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Background
Renovascular hypertension is due to renal artery stenosis 
(RAS) leading to reduced renal perfusion activating the 
renin angiotensin aldosterone system, resulting in hyper-
tension [1]. It accounts for 1–2 % of all cases of hyperten-
sion in the general population [2], and 5.8 % of secondary 
hypertension [3], but plays a major role in completely 
treatable causes of hypertension in the young. Reno-
vascular hypertension is characterized by features like 
hypokalemia, young age of onset, and renal bruit [1]. This 
entity consists of renal vascular atherosclerosis and fibro-
muscular dysplasia (FMD). Atherosclerosis; accounting 
for 90 % of RAS, is seen in the elderly and in those with 
high cardiovascular risk factors. Whereas FMD accounts 
for less than 10 % of RAS, as is seen in females between 
15 and 50 years [1]. FMD is a non-atherosclerotic, non-
inflammatory angiopathy which could affect any vascu-
lar bed, but mainly affects renal arteries [4]. Other rarer 
cause of RAS include aortitis, radiation induced arteritis, 
dissecting aneurysm and von-Recklinghausen’s disease. 
In this paper, we present a case of successfully treated 
young hypertension due to RAS caused by FMD.
Case presentation
A 29  year old Sinhalese Sri Lankan female, who was 
apparently well, presented with incidentally detected 
high blood pressure. She is a mother of two children, but 
had no history of pregnancy induced hypertension.  She 
denied any family history of hypertension. She also com-
plained of loss of appetite and subjective weight loss dur-
ing the past few months.
Her physical examination revealed a blood pressure 
of 180/120  mmHg on two separate occasions, and was 
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equal in both arms. Her pulse rate was 88 beats per min-
ute, with no radio-radial or radio-femoral delay. There 
were no renal masses, and no carotid, renal or femoral 
artery bruits. Her cardiovascular and central nervous sys-
tem examination was unremarkable, and had no evidence 
of retinopathy on fundoscopy. She had no peripheral stig-
mata of atherosclerosis, or endocrinopathies.
Her renal function tests, serum electrolytes, urine 
full report, full blood count, erythrocyte sedimentation 
rate, and liver function tests were all normal. Her elec-
trocardiogram and transthoracic echocardiogram were 
unremarkable.
As she was a recent onset young hypertensive, she was 
investigated with ultrasound scan of the abdomen which 
showed non visualization of the left kidney. Therefore, 
computed tomography angiogram (CTA) and diethylene 
triamine penta acetic acid (DTPA) renogram was indi-
cated. DTPA renogram showed a small left kidney which 
was suggested to be either congenital, or due to RAS, 
with normal perfusion and function of the right kidney. 
CTA revealed significant stenosis of the left main renal 
artery, which was suggested to be due to FMD, and an 
accessory renal artery supplying the lower pole of the left 
kidney was detected (Figs. 1, 2). After evaluation of her 
renovascular hypertension, she was referred to a vascular 
surgeon and underwent left sided nephrectomy, and his-
tology revealed features of FMD of left renal artery. She 
achieved full recovery with normalization of blood pres-
sure following surgery, and is currently not on any anti-
hypertensive medication.
Discussion
FMD is an uncommon angiopathy that predominantly 
affects young to middle-aged females [5], which is non-
atherosclerotic, and non-inflammatory, and most com-
monly affecting the renal and internal carotid arteries, 
but may be seen in any arterial bed [4]. A pathologi-
cal classification of renal artery FMD was proposed by 
McCormack et  al. [6] and revised by Stanley [7]. Three 
main subtypes were identified based on the dominant 
arterial wall layer involved, namely; intimal, medial, and 
adventitial (perimedial) FMD. Intimal, medial, and peri-
medial FMD accounts for 5, 85, and 10 % cases of renal 
artery FMD respectively [2]. A study done by Alimi et al 
found that 66 % of cases had more than one arterial layer 
involved [8]. Aneurysms and dissections are considered 
to be complications of FMD [7].
A definite etiology of FMD is not known, though there 
are various theories. Genetic predisposition is proposed, 
as a study done by Rushton showed 60  % cases to have 
autosomal dominant inheritance pattern with variable 
penetrance [9], and a subsequent case report of disease 
among family members also support this theory [10]. 
Other proposed mechanisms of etiology are hormo-
nal factors, mechanical trauma, metabolic and immu-
nologic factors, and intrinsic deficiency of elastic fibers 
[11]. There is evidence that cigarette smoking may be a 
risk factor [12]. FMD is also associated with pheochro-
mocytoma, neurofibromatosis, Ehlers-Danlos syndrome 
type IV, Marfan’s syndrome, Alport’s syndrome, and 
Takayasu’s arteritis [4]. Atherosclerosis, which is its main 
Fig. 1 Close-up of CT angiogram showing significant left sided renal 
artery stenosis, with an atrophied left kidney, which is supplied by an 
accessory renal artery. There is normal perfusion and function of the 
right kidney
Fig. 2 CT renal angiogram showing atrophic left kidney with non 
visualization of the left main renal artery
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differential diagnosis, is differentiated by being located 
at the ostium or proximal portion of the artery in older 
patients with typical cardiovascular risk factors, where as 
FMD occurs in the middle or distal arterial segments in 
younger patients with few cardiovascular risk factors [4]. 
Unlike RAS due to atherosclerosis, FMD rarely has dete-
rioration of renal function with high serum creatinine 
levels [2]. The other differential diagnosis is Polyarteri-
tis nodosa which shows pathognomonic multiple focal 
aneurysms on renal angiography [13].
FMD accounts for 10–20 % of documented RAS, with 
renovascular hypertension accounting for 1–2  % of 
hypertensives, and the prevalence of clinically significant 
renal artery FMD can be estimated to be about 0.4 % [2]. 
The commonest arterial involvement of FMD is of renal 
arteries (60–75  %), followed by cervico-cranial arteries 
with a prevalence of half that of renal arterial involve-
ment [14], with at least two vascular beds involved in 
up to 28 % cases [15]. The clinical presentation may vary 
from an asymptomatic condition to a multisystem dis-
ease depending on the arterial segment involved, the 
degree of stenosis, and the type of FMD.
The commonest presentation of FMD is renovascular 
hypertention; usually grade 2–3, or resistant hyperten-
sion. The mechanism depends on whether the stenosis 
is unilateral (renin-dependent hypertension) or bilateral/
unilateral with a single functioning kidney (volume-
mediated hypertension) [16]. However 2/3 RAS due to 
FMD are bilateral [17]. Ultimately there is activation of 
the renin angiotensin aldosterone system resulting in 
vasoconstriction, and salt and water retention. FMD may 
be complicated by renal artery dissection and kidney 
infarction with abrupt flank pain, haematuria and rapidly 
progressive hypertension [18].
Various imaging methods are used in the evaluation of 
RAS. Duplex imaging of the renal arteries can accurately 
detect elevated blood-flow velocities in the proximal and 
distal portions of these arteries, but has a 10–20 % failure 
rate due to operator’s inexperience, the presence of obe-
sity or bowel gas, respiratory renal movements, and the 
fact that the possibility of a stenotic accessory renal artery 
cannot be excluded by visualization of a single normal 
renal artery [19]. The current importance of ultrasound 
scan is the ability to predict functional recovery based 
on the measurement of resistive index. Captopril renog-
raphy (DTPA renography) is a safe noninvasive tool used 
in the screening for RAS, but data regarding its reliability 
is inconsistent. Its efficacy is increased by administering 
25–50  mg of captopril 1  h prior to injection of radio-
isotope, and the sensitivity and specificity decreases in 
the presence of azotemia, bilateral disease, or disease of 
solitary functional kidney [20]. Computed tomographic 
angiography is the most specific tool in diagnosis, where 
as gadolinium enhanced magnetic resonance angiog-
raphy has the additional advantage of not having radia-
tion exposure, and limited nephrotoxicity. However both 
modalities have high specificity, but low sensitivity [21]. 
The gold standard in diagnosing renal artery FMD is 
intra-arterial angiogram with digital substraction, but is 
reserved for patients for whom it is clinically justified to 
proceed with revascularization in the same procedure, as 
it is an invasive test. Multifocal stenosis with the “string 
of beads” appearance is characteristic of FMD, which 
likely indicates the presence of medial type FMD, where 
as other features are tubular or focal lesions [22].
Pharmacological treatment of hypertension in FMD 
should follow the guidelines of the Joint National Com-
mittee on prevention, detection, evaluation and treat-
ment of high blood pressure [23]. Almost all patients 
with RAS require at least one antihypertensive agent, and 
require three or more medications twice as frequently as 
those with cerebrovascular FMD [24]. Revascularization 
is the choice of treatment in patients with young hyper-
tension refractory to pharmacological therapy, those 
who are intolerant to antihypertensive, those who have 
lost renal volume due to ischaemic nephropathy, and the 
goal is to cure the disease [4]. Surgical revascularization 
was the primary treatment modality before the intro-
duction of percutaneous transluminal angioplasty tech-
niques (PTA), and leads to improvement of hypertension 
in 60–88  % cases [24, 25]. Nowadays PTA has emerged 
as a mainstay of treatment for patients with FMD who 
meet the criteria for interventions, and leads to improve-
ment or resolution of hypertension in 60–80 % of cases 
[24, 25]. It is less costly than surgical revascularization 
and less invasive, and can be performed on an outpa-
tient basis and has a lower morbidity [4]. Complications 
of percutaneous interventions occur in 14 % of cases and 
usually minute but rarely renal artery perforation, dissec-
tion or segmental renal infarctions may occur [27–29]. 
Successfully performed renal angioplasty results in sub-
stantial and rapid reduction in both systolic and diastolic 
blood pressure to normal values and it correlates with a 
marked reduction in plasma renin activity and angioten-
sin II levels [4, 30]. Complete resolution of hypertension 
without the requirement of antihypertensive medication 
may be achieved only in 30–50  % cases [24, 25]. Imag-
ing should be performed soon after revascularization 
process to assess the adequacy of the intervention [31], 
again in 6 months, 12 months and yearly there after [3]. 
When the criteria for revascularization are not met, or 
in extreme hypertension, or following failed primary sur-
gery, or when a kidney is non-viable nephrectomy can be 
performed as in this case, resulting in complete cure [25].
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Conclusions
FMD causing RAS, though a rare cause of renovascu-
lar hypertension is essential to be considered in young 
hypertensives, even in the absence of family history of 
hypertension. A high index of suspicion is necessary in 
early diagnosis and prompt treatment, which would 
result in rapid and complete recovery.
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